摘要
目的:研究丙戊酸对癫痫患者骨代谢的影响。方法:癫痫患者组34例于丙戊酸治疗前、治疗后3个月及6个月分别测定血钙(Ca)、血磷(P)、骨性碱性磷酸酶(BAP)、骨钙素(BGP)、甲状旁腺素(PTH)、1,25-二羟维生素D3[1,25-(OH)2VitD3]、降钙素(CT)及尿脱氧吡啶啉(DPD)、肌酐(Cr);并设正常对照组30例。结果:两组治疗前骨代谢无显著差异;治疗组治疗后3个月、6个月CT、BAP、BGP、DPD、Cr均较治疗前明显升高(P<0.05),1,25-(OH)2VitD3较治疗前明显下降(P<0.05)。结论:丙戊酸治疗癫痫患儿可致骨代谢异常,骨形成及骨吸收均明显活跃。
Objective: To study the effect of valproate on bone metabolism in children with epilepsy. Methods: Calcium (Ca), phosphorum (P), bone alkaline phosphate (BAP), bone carboxyglutamate protein (BGP), parathormone (PTH), 1,25-(OH)2VitD3, calcitonin (CT) in serum and deoxypyridinoline (DPD), creatinine (Cr) in urine were measured in 34 epilepsy children treated with valproate before and 3 or 6 months after the treatment, so did in the control group of 30 healthy children. Results: There was no significant difference in bone metabolism between the therapy and the control group before the treatment. Ca, P and PTH serums levels showed no significant changes 3 or 6 months after the treatment while the CT, BAP, BGP, DPD,Cr were higher and 1,25-(OH)2VitD3 serum levels were lower than that be fore the treatment(P 〈 0.05). Conclusion: Valproate treatment in epileply activates bone resorption and bone formation, which lead to abnormal bone metabolism.
出处
《儿科药学杂志》
CAS
2005年第6期5-7,共3页
Journal of Pediatric Pharmacy
关键词
丙戊酸
癫痫
骨代谢
儿童
Valproate
Epilepsy
Bone metabolism
Children